, Tracking Stock Market Picks
Enter Symbol:
Impax Laboratories, Inc. (IPXL) [hlAlert]

up 87.50 %

Impax Laboratories, Inc. (IPXL) rated Buy with price target $29 by Goldman

Posted on: Monday,  Dec 16, 2013  8:25 AM ET by Goldman

Goldman rated Buy Impax Laboratories, Inc. (NASDAQ: IPXL) on 12/16/2013, when the stock price was $23.45. Since
then, Impax Laboratories, Inc. has gained 87.51% as of 01/20/2016's recent price of $43.97.
If you would have followed this Goldman's recommendation on IPXL, you would have gained 87.5% of your investment in 765 days.

Impax Laboratories, Inc. is a technology-based, specialty pharmaceutical company. The Company is focused on the development and commercialization of bioequivalent and brand-name pharmaceuticals, utilizing its controlled-release and other in-house development and formulation expertise. In the generic pharmaceuticals market, the Company focuses its efforts on controlled-release generic versions of selected brand-name pharmaceuticals covering a range of therapeutic areas. In the brand-name pharmaceuticals market, Impax is developing products for the treatment of central nervous system (CNS), disorders. Its brand-name product portfolio consists of development-stage projects to which it is applying its formulation and development expertise to develop differentiated, modified, or controlled-release versions of marketed drug substances. The Company operates in two segments: Global Pharmaceuticals Division (Global Division) and the Impax Pharmaceutical Division (Impax Division).

Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
12/16/2013 8:25 AM Buy
23.45 29.00
as of 8/27/2015
1 Week down  -6.58 %
1 Month down  -8.83 %
3 Months down  -1.89 %
1 YTD up  74.90 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy